Identification of Francisella tularensis cluster in central and western Europe.
Thirteen F. tularensis isolates collected over the past 10 years in Switzerland (Figure 1) were subjected to extensive genetic characterization. The species and subspecies designations of all strains were confirmed by real-time PCR that targeted the fopA gene and by amplification of the RD1 region (8), which showed that all strains were F. tularensis subsp. holarctica. A reference panel of 12 F. tularensis subsp. holarctica strains (7) and the genome sequence of the strain isolated in France, FTNF002 (GenBank accession no. NC_009749), were included in the study to represent the currently known genetic subpopulations within the subspecies. All strains from Switzerland were genetically characterized at 6 highly variable loci (by MLVA) and 14 more stable loci that indicate the classification F. tularensis subsp. holarctica strains into genetic subpopulations (by Ftind analysis) (3,6,7). The RD analysis was also performed because a 1.59-kb deletion marker, RD23, was reported to be restricted to strains from France and Spain (3). The MLVA markers (M3, M6, M20, M21, M22, and M24) and Ftind markers (Ftind 25-38) were amplified by PCR and then sequenced with an ABI Prism 3100 genetic analyzer (Applied Biosystems, Foster City, CA, USA) and the BigDye Terminator cycle sequencing kit (Applied Biosystems). DNA fragment sizes were calculated from the nucleotide sequences of the MLVA and Ftind markers and used to compare the isolates with previously analyzed strains from the United States, Japan, France, and Russia (3,7). The RD23 marker was assayed by using standard PCR and agarose gel methods as previously described (3). A cluster analysis based on the MLVA and indel size data was performed by using BioNumerics version 3.5 (Applied Maths, Kortrjik, Belgium).
[FIGURE 1 OMITTED]
As expected, the indel markers served to place each strain into major branches of the cluster tree, and the more variable MLVA markers provided the fine resolution at the tips of the tree. The Switzerland strains belonged to the same genetic cluster as the F. tularensis strain FTNF002 from France (Figure 1) that in a previous work clustered with strains from Spain (3,9). Moreover, all the Swiss strains exhibited the 1.59-kb genomic deletion at the RD23 locus and the unique 464-bp size at MLVA marker M24, which confirmed their close relationship to the French strain FTNF002 as well as to other strains from France and Spain (3).
The finding of F. tularensis strains in Switzerland represent sporadic occurrences of tularemia without any obvious epidemiologic connection. The strains originated from 6 hares, 3 monkeys, and 4 persons and were collected at different locations in Switzerland over a period of 10 years (Figure 2). The human infections most likely occurred through direct contact with wild animals, through rodent bites, and through consumption of a hare cooked at low temperature. Those isolates could be resolved into 7 different genotypes (Figure 2). Four Swiss strains displayed a genetic profile identical to that of the representative French strain FTNF002 (3). The other 6 genotypes were closely related to FTNF002, and all corresponded to the subclade B.Br:FTNF002-00 as defined by canonical single nucleotide polymorphisms by Vogler et al. (9). This cluster, which also contained the strains from the Iberian Peninsula, seems to have spread throughout central and western Europe. Moreover, all the Swiss strains were susceptible to erythromycin (MICs 0.25 [micro]g/mL to 1 [micro]g/mL), which is a phenotypic marker that has previously been suggested to divide F. tularensis subsp. holarctica strains into 2 taxonomic groups (10-12).
[FIGURE 2 OMITTED]
Strains of F. tularensis from Switzerland (central Europe) genetically clustered with strains from France and Spain (western Europe) as determined by the unique 464-bp genetic marker M24 and a specific deletion at marker RD23. Furthermore, strains within the cluster differed at only 2 MLVA markers,and 4 other MLVA and 14 Ftind markers were identical. In a previous study that included strains from the 1997-1998 tularemia outbreak in Spain, the specific M24 allele and the RD23 deletion were found in 49 of 49 strains from Spain and France but in only 1 of 189 strains from 7 northern and eastern European countries and Japan (3). The tularemia outbreak of 1997-1998 in Spain, which resulted in >500 human cases (5), was thus caused by F. tularensis strains that were genetically closely related to strains recovered in Switzerland from 1996 onwards, before the beginning of the outbreaks in Spain. This genetic relationship shows that factors other than the presence or introduction of a specific clone of the infectious agent per se determined the magnitude of the tularemia outbreaks in Spain. For epidemiologists to understand the distribution of F. tularensis (and other rare disease agents) in the environment and their propagation across national and geographic borders, surveillance programs that include molecular analyses of these agents should be undertaken in multiple countries, and the resulting data should be shared internationally.
We thank M. Wittenbrink for the gift of strains and A. Tarnvik for critical comments on the manuscript.
This work was supported by grants from the Swiss Federal Office of Public Health, the Medical Faculty at Umea University, Vasterbottens lans landsting, and the Swedish Defense Research Agency.
(1.) Avashia SB, Petersen JM, Lindley CM, Schriefer ME, Gage KL, Cetron M, et al. First reported prairie dog-to-human tularemia transmission, Texas, 2002. Emerg Infect Dis. 2004;10:483-6.
(2.) Siret V, Barataud D, Prat M, Vaillant V, Ansart S, Le Coustumier A, et al. An outbreak of airborne tularaemia in France, August 2004. Euro Surveill. 2006;11:58-60.
(3.) Dempsey MP, Dobson M, Zhang C, Zhang M, Lion C, Gutierrez-Martin CB, et al. Genomic deletion marking an emerging subclone of Francisella tularensis subsp. holarctica in France and the Iberian Peninsula. Appl Environ Microbiol. 2007;73:7465-70. DOI: 10.1128/AEM.00646-07
(4.) Kantardjiev T, Ivanov I, Velinov T, Padeshki P, Popov B, Nenova R, et al. Tularemia outbreak, Bulgaria, 1997-2005. Emerg Infect Dis. 2006;12:678-80.
(5.) Martin C, Gallardo MT, Mateos L, Vian E, Garcia MJ, Ramos J, et al. Outbreak of tularaemia in Castilla y Leon, Spain. Euro Surveill. 2007;12:E071108.1.
(6.) Johansson A, Farlow J, Larsson P, Dukerich M, Chambers E, Bystrom M, et al. Worldwide genetic relationships among Francisella tularensis isolates determined by multiple-locus variable-number tandem repeat analysis. J Bacteriol. 2004;186:5808-18. DOI: 10.1128/JB.186.17.5808-5818.2004
(7.) Larsson P, Svensson K, Karlsson L, Guala D, Granberg M, Forsman M, et al. Canonical insertion-deletion markers for rapid DNA typing of Francisella tularensis. Emerg Infect Dis. 2007;13:1725-32.
(8.) Broekhuijsen M, Larsson P, Johansson A, Bystrom M, Eriksson U, Larsson E, et al. Genome-wide DNA microarray analysis of Francisella tularensis strains demonstrates extensive genetic conservation within the species but identifies regions that are unique to the highly virulent F. tularensis subsp. tularensis. J Clin Microbiol. 2003;41:2924-31. DOI: 10.1128/JCM.41.7.2924-2931.2003
(9.) Vogler AJ, Birdsell D, Price LB, Bowers JR, Beckstrom-Sternberg SM, Auerbach RK, et al. Phylogeography of Francisella tularensis: global expansion of a highly fit clone. J Bacteriol. 2009;191:2474-84. DOI: 10.1128/JB.01786-08
(10.) Urich SK, Petersen JM. In vitro susceptibility of isolates of Francisella tularensis types A and B from North America. Antimicrob Agents Chemother. 2008;52:2276-8. DOI: 10.1128/AAC.01584-07
(11.) Ikaheimo I, Syrjala H, Karhukorpi J, Schildt R, Koskela M. In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals. J Antimicrob Chemother. 2000;46:287-90. DOI: 10.1093/jac/46.2.287
(12.) Tomaso H, Al Dahouk S, Hofer E, Splettstoesser WD, Treu TM, Dierich MP, et al. Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains. Int J Antimicrob Agents. 2005;26:279-84. DOI: 10.1016/j.ijantimicag.2005.07.003
Paola Pilo,  Anders Johansson,  and Joachim Frey
 These authors contributed equally to this work.
Author affiliations: University of Bern, Bern, Switzerland (P. Pilo, J. Frey); Umea University, Umea, Sweden (A. Johansson); and Swedish Defence Research Agency, Umea (A. Johansson)
Address for correspondence: Joachim Frey, 122 Laenggassstrasse, 3001 Bern, Switzerland; email: firstname.lastname@example.org
Dr Pilo is a research associate at the Institute for Veterinary Bacteriology, University of Bern, Switzerland. Her primary research interest is host-pathogen interactions.
|Printer friendly Cite/link Email Feedback|
|Author:||Pilo, Paola; Johansson, Anders; Frey, Joachim|
|Publication:||Emerging Infectious Diseases|
|Date:||Dec 1, 2009|
|Previous Article:||Age patterns of persons with campylobacteriosis, England and Wales, 1990-2007.|
|Next Article:||New adenovirus in bats, Germany.|